Drug-induced serotonin syndrome: a review (Q51886952)

16 April 2018

review article

1 reference

title

Drug-induced serotonin syndrome: a review (English)

1 reference

16 April 2018

0 references

1 reference

Stewart J Tepper

1 reference

16 April 2018

author name string

Christina Sun-Edelstein

series ordinal

1 reference

16 April 2018

Robert E Shapiro

series ordinal

1 reference

16 April 2018

language of work or name

English

0 references

publication date

1 September 2008

1 reference

16 April 2018

Expert Opinion on Drug Safety

published in

1 reference

16 April 2018

volume

1 reference

16 April 2018

issue

1 reference

16 April 2018

page(s)

587-596

1 reference

16 April 2018

Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

21 January 2018

The Serotonin Syndrome

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

21 January 2018

The serotonin syndrome

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

2002 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Interactions of non-selective monoamine oxidase inhibitors, tranylcypromine and nialamide, with inhibitors of 5-hydroxytryptamine, dopamine or noradrenaline re-uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Interactions between relatively selective monoamine oxidase inhibitors and an inhibitor of 5-hydroxytryptamine re-uptake, clomipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Diazepam and chlormethiazole attenuate the development of hyperthermia in an animal model of the serotonin syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Functional study of rat 5‐HT2A receptors using antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Memantine, an NMDA antagonist, prevents the development of hyperthermia in an animal model for serotonin syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Serotonin toxicity and malignant hyperthermia: role of 5-HT2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

The pathophysiology of serotonin toxicity in animals and humans: implications for diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Making sense of serotonin toxicity reports, a comment on Chopra et Al. (World J Biol Psychiatry 2004, 5: 114-115).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

The serotonin syndrome and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Selective serotonin reuptake inhibitor-induced serotonin syndrome: review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Serotonin syndrome. Presentation of 2 cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

The serotonin syndrome scale: first results on validity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Moclobemide poisoning: toxicokinetics and occurrence of serotonin toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

'Atypical' antidepressants in overdose: clinical considerations with respect to safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Actions of tramadol, its enantiomers and principal metabolite, O-desmethyltramadol, on serotonin (5-HT) efflux and uptake in the rat dorsal raphe nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Moclobemide and the risk of serotonin toxicity (or serotonin syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Moclobemide: Therapeutic Use and Clinical Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Serotonergic synergism: the risks and benefits of combining the selective serotonin reuptake inhibitors with other serotonergic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

21 January 2018

MAOI and cardiac surgery

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Adverse effects of opioid agonists and agonist-antagonists in anaesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Monoamine oxidase inhibitors and anaesthesia. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

MAO inhibitors and coronary artery surgery: a patient death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Fentanyl-induced rigidity during emergence from general anesthesia potentiated by venlafexine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Safe use of remifentanil in a patient treated with the monoamine oxidase inhibitor phenelzine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Combining Stimulants With Monoamine Oxidase Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Monoamine transporters and psychostimulant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

The serotonin syndrome, triptans, and the potential for drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Serotonin syndrome associated with triptan monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Lithium and venlafaxine interaction: a case of serotonin syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

A case of serotonin syndrome caused by venlafaxine and lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Adverse reactions to mirtazapine are unlikely to be serotonin toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

Mirtazapine: unable to induce serotonin toxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.7.5.587

21 January 2018

Identifiers

DOI

10.1517/14740338.7.5.587

1 reference

16 April 2018

1 reference

16 April 2018